Resources

Cover page in blue with title and image of people sitting on the ground listening to.a training

Microplanning manual to guide implementation of preventive chemotherapy to control and eliminate neglected tropical diseases

WHO manual on implementing preventative chemotherapy against neglected tropical diseases provides generic tools for those involved in planning preventative chemotherapy administration. The publication was released in September 2022.
Cropped image of document cover page

WHO standard operating procedures for supply chain management of health products for neglected tropical diseases amenable to preventive chemotherapy

New WHO standard operating procedures--released on July 25, 2022--describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them.
Cover of WHO Guideline

WHO guideline on control and elimination of human schistosomiasis

New WHO guideline--released on February 14, 2022--outlines guidelines for preventive chemotherapy, safety of praziquantel for treatment, WASH and snail control interventions and verification of interruption of transmission of human schistosomiasis. 

Global Health Science and Practice Technical Exchange

Global Health Science and Practice Technical Exchange

The Global Health Science and Practice Technical Exchange (GHTechX) took place virtually from April 21 - 24, 2021. The event is curated through a partnership between USAID, the George Washington University, and the Global Health: Science and Practice Journal. Our goal is to convene speakers and technical sessions that highlight the latest and greatest in global health, with participants spanning global health experts, students, and professionals from across the global health community.
Trachoma Surveys: Practical Approaches to Implementing WHO Guidance for Neglected Tropical Disease (NTD) Programs in the Context of COVID-19

Trachoma Surveys: Practical Approaches to Implementing WHO Guidance for Neglected Tropical Disease (NTD) Programs in the Context of COVID-19

Trachoma baseline surveys, trachoma impact surveys, trachoma surveillance surveys, and trichiasis-only surveys are key disease-specific assessments of trachoma elimination programs, used to start mass drug administration (MDA), monitor progress, decide when to stop MDA, and inform attainment of elimination of trachoma as a public health problem.
Act to End NTDs | West Aperçu du Programme

Act to End NTDs | West Aperçu du Programme

Cette brochure résume le travail de la loi de l'USAID pour mettre fin aux MTN | Programme Ouest, qui donne une vue d’ensemble des activités du programme et des progrès accomplis à ce jour alors que nous continuons à prendre des mesures pour perturber les dommages causés par les maladies débilitantes de la pauvreté. Construit sur la base d'une large coopération internationale et mis en œuvre par un consortium solide de partenaires profondément engagés, dirigé par FHI 360, Act | West travaille en étroite collaboration avec les gouvernements de 11 pays africains pour éliminer et contrôler à long terme cinq des MTN les plus courantes au monde.
USAID's Act | West Program Snapshot

Act to End NTDs | West Program Snapshot

This brochure summarizes the work of USAID's Act to End NTDs | West Program, providing a big picture look at program activities and progress to date as we continue taking action to disrupt the damage of debilitating diseases of poverty. Built on a foundation of broad international cooperation and implemented by a strong consortium of deeply committed partners, led by FHI 360, Act | West works closely with the governments of 11 African countries to eliminate and control five of the world’s most common NTDs over the long term.
Model overview

Considerations for developing and deploying cost and economic impact models in the elimination/control of 5 PCT NTDs

The economic impact model and supporting disease-specific tools estimate the direct and indirect economic impact, efficiencies, and societal benefits of investing in NTD programs and interventions. The workshop will explain how NTD programs can use the supporting tools to develop investment cases to advocate for domestic resources and prioritize NTD investments in a multi-disease environment. It will also describe how, with support from HKI and Deloitte, Sierra Leone’s NTD program will pilot these tools and serve as the advisor on country needs, program and financial data, user testing of the tools, and utilization of the outputs for advocacy. After incorporating the feedback from the pilot in Sierra Leone, the Act | West team will make the tools available to all supported countries to create investment cases that enhance advocacy efforts for domestic resource mobilization for NTD programming.
USAID's Act to End NTDs | West's Arielle Dolegui

Cross-sector approaches for sustainable service delivery: Integration with education and health for sustainable NTD programming

As Ministries of Education oversee the institutions that are critical platforms for deworming, health education, linkages to health services, and collaboration between education and health provide unique opportunities for NTD service delivery and sustainability. Ms. Dolegui will present approaches from Ghana, Senegal, and Sierra Leone and discuss opportunities to strengthen collaboration.
Risk factors associated with failing pre-transmission assessment surveys (pre-TAS) in lymphatic filariasis elimination programs: Results of a multi-country analysis

Risk factors associated with failing pre-transmission assessment surveys (pre-TAS) in lymphatic filariasis elimination programs: Results of a multi-country analysis

This paper reports for the first time factors associated with pre-transmission assessment survey (pre-TAS) results from a multi-country analysis. This information can help countries more effectively forecast program activities, such as the potential need for more rounds of mass drug administration, and prioritize resources to ensure adequate coverage of all persons in areas at highest risk of failing pre-TAS.